Cardiol Therapeutics Inc. (CRDL) stock
CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$0.86−0.02 (-2.28%)
Close on Nov 20, 2026Market cap $86.48MP/E –Yield –
Cardiol Therapeutics total assets
Total assets on the balance sheet at the end of each period.
Cardiol Therapeutics's total assets was C$23.62M at Dec 31, 2025. For fiscal 2025 it was C$23.62M, down 25.9% from the year before. The highest annual figure on record is C$87.88M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | C$23.62M | -25.9% |
| FY2024 | Dec 31, 2024 | C$31.86M | -13.2% |
| FY2023 | Dec 31, 2023 | C$36.70M | -40.8% |
| FY2022 | Dec 31, 2022 | C$62.03M | -29.4% |
| FY2021 | Dec 31, 2021 | C$87.88M | +452.9% |
| FY2020 | Dec 31, 2020 | C$15.89M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q4 FY2025 | Dec 31, 2025 | C$23.62M | -73.1% |
| Q4 FY2024 | Dec 31, 2024 | C$31.86M | +100.5% |
| Q4 FY2023 | Dec 31, 2023 | C$36.70M | – |
| Q4 FY2022 | Dec 31, 2022 | C$62.03M | – |
| Q4 FY2021 | Dec 31, 2021 | C$87.88M | – |
| Q4 FY2020 | Dec 31, 2020 | C$15.89M | – |
See a number that looks wrong?